The publication of University of Health Sciences, Istanbul Sisli Hamidiye Etfal Medical Practice and Research Center

Online article submission system has been turned over to eJManager. We kindly request you to submit your current article or new articles via eJManager system

          VOLUME 49 / ISSUE 4

The Journal is Indexed in

2 - The importance of prediabetes and therapeutic approach

Yüksel Altuntaş, Feyza Yener Öztürk

Prediabetes is the intermediate period between normoglycemia and type 2 diabetes mellitus. Fasting plasma glucose concentration between 100 and 125 mg/dl (Impaired fasting glucose) or second hour plasma glucose concentration of oral glucose tolerance test between 140-199 mg/dl (Impaired glucose tolerance) is termed as prediabetes. Also, HbA1c level between 5.7-6.4% has been accepted as prediabetes according to the recommendations of ADA in 2010. Every year 5 to 10% of prediabetic patients progress into type 2 diabetes mellitus. As associated with dislipidemia, hypertension and obesity, prediabetes is an important risk factor for developing cardiovascular diseases. So, early diagnosis and treatment for prediabetes may interfere in preventing type 2 diabetes development.

Keywords: Prediabetes, type 2 diabetes, impaired glucose tolerance, impaired fasting glucose

To read full article click

Home Page       Editorial       Editorial Board       Advisory Board       Information for Authors       Contact       Archive

Copyright ® 2011 Sisli Etfal Hastanesi Tıp Bülteni